Vimian Group AB (publ) (OTCMKTS:VIMGF) Short Interest Up 122.2% in February

Vimian Group AB (publ) (OTCMKTS:VIMGFGet Free Report) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 174,400 shares, a growth of 122.2% from the February 13th total of 78,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Vimian Group AB (publ) Stock Performance

VIMGF stock opened at C$3.50 on Friday. Vimian Group AB has a 52 week low of C$2.68 and a 52 week high of C$4.12. The firm has a 50 day moving average of C$3.50 and a 200 day moving average of C$3.72.

About Vimian Group AB (publ)

(Get Free Report)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.

Read More

Receive News & Ratings for Vimian Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vimian Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.